Table 3.
The glycemic control in diabetic patients with and without chronic complications
| T2DM chronic complications* | HbA1c | |||
|---|---|---|---|---|
| Mean ± SD(%) | < 6.5%(%) | 6.5%-7.5%(%) | > 7.5%(%) | |
| Without chronic conditions(n = 727) | 8.0 ± 1.6 | 111 (15.3) | 213(29.3) | 403(55.4) |
| With chronic conditions(n = 784) † | 8.2 ± 1.6 | 95 (12.1) | 195(24.9) | 494(63.0) |
| Cardiovascular conditions(n = 457) | 8.0 ± 1.5 | 64(14.0) | 121(26.5) | 272(59.5) |
| Neuropathy(n = 268) | 8.0 ± 1.6 | 40(14.9) | 66(24.6) | 162(60.4) |
| Cerebrovascular conditions(n = 103) | 8.2 ± 1.7 | 16(15.5) | 23(22.3) | 64(62.1) |
| Nephropathy conditions(n = 160) | 8.3 ± 1.7 | 19(11.9) | 34(21.3) | 107(66.9) |
| Ocular conditions(n = 221) | 8.6 ± 1.7 | 19(8.6) | 43(19.5) | 159(71.9) |
| Foot diseases(n = 12) | 8.1 ± 2.0 | 3(25.0) | 3(25.0) | 6(50.0) |
*: Results of HbA1c tests were not available for five patients without chronic conditions and 8 with complications.
†: Patients with multiple category conditions were counted repeatedly under each category.